Kon Zachary N, Brown Emile N, Tran Richard, Joshi Ashish, Reicher Barry, Grant Michael C, Kallam Seeta, Burris Nicholas, Connerney Ingrid, Zimrin David, Poston Robert S
Division of Cardiac Surgery, Department of Surgery, University of Maryland Medical System, Baltimore, MD 21201, USA.
J Thorac Cardiovasc Surg. 2008 Feb;135(2):367-75. doi: 10.1016/j.jtcvs.2007.09.025. Epub 2007 Dec 26.
Less-invasive options are available for surgical treatment of multivessel coronary artery disease. We hypothesized that stenting combined with grafting of the left anterior descending artery with the left internal thoracic artery through a minithoracotomy (hybrid procedure) would provide the best outcome.
Patients with equivalent numbers of coronary lesions (2.8 +/- 0.4) underwent either hybrid (n = 15) or off-pump coronary artery bypass through a sternotomy (n = 30). Early and 1-year outcomes were compared. Blood drawn from the aorta and coronary sinus immediately postoperatively was analyzed for activation of coagulation (prothrombin fragment 1.2 and activated Factor XII), myocardial injury (myoglobin), and inflammation (interleukin 8) by using an enzyme-linked immunosorbent assay. Target-vessel patency was determined by means of computed tomographic angiographic analysis.
The hybrid procedure was associated with significantly shorter lengths of intubation and stays in the intensive care unit and hospital and perioperative morbidity (P < .05). Intraoperative costs were increased but postoperative costs were reduced for the hybrid procedure compared with off-pump coronary artery bypass through a sternotomy. As a result, overall total costs were not significantly different between the groups. After adjusting for potential confounders, assignment to the hybrid group was an independent predictor of shortened time to return to work (t = -2.12, P = .04). Patient satisfaction after the hybrid procedure, as judged on a 6-point scale, was greater versus that after off-pump coronary artery bypass through a sternotomy. Finally, the hybrid procedure showed significantly reduced transcardiac gradients of markers of coagulation, myocardial injury, and inflammation and a trend toward significant improvement in target-vessel patency.
Perhaps because of reduced myocardial injury, inflammation, and activation of coagulation, patients undergoing the hybrid procedure had better perioperative outcomes and satisfaction, with excellent patency at 1 year's follow-up. These promising preliminary findings warrant further investigation of this procedure.
对于多支冠状动脉疾病的外科治疗,有侵入性较小的选择。我们假设通过微创胸廓切开术将支架置入与左前降支动脉与左胸廓内动脉移植相结合(杂交手术)能带来最佳结果。
冠状动脉病变数量相当(2.8±0.4)的患者分别接受杂交手术(n = 15)或通过胸骨切开术进行非体外循环冠状动脉搭桥术(n = 30)。比较早期和1年的结果。术后立即从主动脉和冠状窦采集血液,采用酶联免疫吸附测定法分析凝血激活(凝血酶原片段1.2和活化的因子Ⅻ)、心肌损伤(肌红蛋白)和炎症(白细胞介素8)情况。通过计算机断层血管造影分析确定靶血管通畅情况。
杂交手术与插管时间、重症监护病房停留时间、住院时间和围手术期发病率显著缩短相关(P < 0.05)。与通过胸骨切开术进行的非体外循环冠状动脉搭桥术相比,杂交手术的术中成本增加,但术后成本降低。因此,两组之间的总体总成本无显著差异。在对潜在混杂因素进行调整后,分配到杂交组是恢复工作时间缩短的独立预测因素(t = -2.12,P = 0.04)。根据6分制判断,杂交手术后患者的满意度高于通过胸骨切开术进行的非体外循环冠状动脉搭桥术。最后,杂交手术显示凝血标志物、心肌损伤标志物和炎症的跨心脏梯度显著降低,靶血管通畅有显著改善的趋势。
也许由于心肌损伤、炎症和凝血激活减少,接受杂交手术的患者围手术期结果和满意度更好,在1年随访时通畅情况良好。这些有前景的初步发现值得对该手术进行进一步研究。